Enovis (ENOV) Cash from Operations (QoQ) (2010 - 2026)
Enovis (ENOV) Cash from Operations (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Enovis | 1.26 Bn | 1.23 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -72.95% |
| Dec 31, 2025 | 7.23% |
| Oct 3, 2025 | 72.87% |
| Jul 4, 2025 | 3,093.05% |
| Apr 4, 2025 | -101.81% |
| Dec 31, 2024 | 64.93% |
| Sep 27, 2024 | 589.01% |
| Jun 28, 2024 | 121.50% |
| Mar 29, 2024 | -152.85% |
| Dec 31, 2023 | 120.60% |
| Sep 29, 2023 | 10.35% |
| Jun 30, 2023 | 276.87% |
| Mar 31, 2023 | 120.74% |
| Dec 31, 2022 | -285.26% |
| Sep 30, 2022 | 177.98% |
| Jul 1, 2022 | -72.57% |
| Apr 1, 2022 | -114.99% |
| Dec 31, 2021 | -0.94% |
| Oct 1, 2021 | 23.94% |
| Jul 2, 2021 | -7.12% |